1
|
Grohé C, Wehler T, Henschke S, Dittrich I, Hammerschmidt S, Aulmann C, Dechow T, Schiefer C, von der Heyde E, Schuette W, Atz J, Kaiser R. 1143P Effect of best response to first-line (1L) treatment (tx) on outcomes with second-line (2L) nintedanib (NIN) + docetaxel (DOC) for patients (pts) with lung adenocarcinoma after 1L immune checkpoint inhibitor (ICI) combination therapy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
2
|
Dittrich I, Gertz M, Maassen-Francke B, Krudewig KH, Junge W, Krieter J. Estimating risk probabilities for sickness from behavioural patterns to identify health challenges in dairy cows with multivariate cumulative sum control charts. Animal 2022; 16:100601. [DOI: 10.1016/j.animal.2022.100601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 06/30/2022] [Accepted: 07/01/2022] [Indexed: 11/16/2022] Open
|
3
|
Grohé C, Wehler T, Dechow T, Henschke S, Schütte W, Dittrich I, Hammerschmidt S, Müller-Huesmann H, Schumann C, Krüger S, Atz J, Kaiser R. 1330P Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
4
|
Dittrich I, Gertz M, Maassen-Francke B, Krudewig KH, Junge W, Krieter J. Variable selection for monitoring sickness behavior in lactating dairy cattle with the application of control charts. J Dairy Sci 2021; 104:7956-7970. [PMID: 33814146 DOI: 10.3168/jds.2020-19680] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Accepted: 02/13/2021] [Indexed: 11/19/2022]
Abstract
The present observational study investigated the application of multivariate cumulative sum (MCUSUM) control charts by including variables selected by principal component analysis and partial least squares (PLS) regression to identify sickness behavior in dairy cattle. Therefore, sensor information (24 variables) was collected from 480 milking cows on a German dairy farm between September 2018 and December 2019. These variables were gathered in potentially different scenarios on farm. In total, data from 749 animals were available for evaluation. Variables were chosen based on the information of 499 cows (62 healthy; 437 sick) with 93,598 observations. The available diagnoses were collected together to form 1,025 sickness events. Hence, the different numbers of selected variables were included into the MCUSUM control charts. The performance of the MCUSUM control charts was evaluated by a 10-fold cross validation; hence, 90% of the original data set (749 cows) represented the training data, and the remaining 10% was used to test the training results. On average, the 10 training data sets included 124,871 observations with 1,392 sickness events, and the 10 testing data sets included, on average, 13,704 observations with 153 sickness events. The MCUSUM generated from the variables selected by principal component analysis showed comparable results in training and testing in all scenarios; therefore, 70.0 to 97.4% of the sickness events were detected. The false-positive rates ranged from 8.5 to 29.6%, and thus they created at least 2.6 false-positive alerts per day in testing. The variables selected by the PLS regression approach showed comparable sickness detection rates (70.0-99.9%) as well as false-positive rates (8.2-62.8%) in most scenarios. The best performing scenario produced 2.5 false-positive alerts in testing. Summarizing, both approaches showed potential for practical implementation; however, the PLS variable selection approach showed fewer false positives. Therefore, the PLS regression approach could generate a more reliable sickness detection algorithm, if combined with MCUSUM control charts, and considered for practical implementation.
Collapse
Affiliation(s)
- I Dittrich
- Institute of Animal Breeding and Husbandry, Christian-Albrechts-University, Olshausenstraße 40, D-24098 Kiel, Germany.
| | - M Gertz
- Institute of Animal Breeding and Husbandry, Christian-Albrechts-University, Olshausenstraße 40, D-24098 Kiel, Germany
| | | | - K-H Krudewig
- 365FarmNet Group GmbH & Co. KG, D-10117 Berlin, Germany
| | - W Junge
- Institute of Animal Breeding and Husbandry, Christian-Albrechts-University, Olshausenstraße 40, D-24098 Kiel, Germany
| | - J Krieter
- Institute of Animal Breeding and Husbandry, Christian-Albrechts-University, Olshausenstraße 40, D-24098 Kiel, Germany
| |
Collapse
|
5
|
Abstract
The recent development of dairy production is characterised by increasing herd sizes and therefore increasingly complicated visual observation of cow behaviour, which is traditionally the basis for diagnoses of production diseases. The limitation of the direct visual behavioural observation due to the increasing number of individual cows implies a growing need for an automated detection of changes within behavioural patterns to identify cows that show sickness behaviour. Sensor systems can be used to measure behavioural patterns such as activity, resting, feeding and rumination. Behavioural patterns change with the occurrence of sickness but also interact with external factors. Changes such as prolonged lying duration or shortened feeding duration caused by metabolic disorders or infections, respectively, then serve as a detection tool for sick individuals. The aim of the present review is to outline the impact of production diseases on the daily behavioural patterns of dairy cows by referring to sickness behaviour.
Collapse
|
6
|
Schumann C, Heigener D, Dittrich I, Bojko P, Abenhardt W, Bosse D, Dederke B, Duell T, Matzdorff A, Raack B, Steins M, Schneider C. Vorteile in der Langzeittherapie mit Erlotinib ist unabhängig von prognostischen Faktoren und Therapieansprechen. Pneumologie 2010. [DOI: 10.1055/s-0030-1251339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
7
|
Serke M, Dittrich I, Bohnenstengel A, Loddenkemper R. Erfahrungen mit der Therapie mit ZD 1839 (IRESSA) im Rahmen eines „expanded acces-Programmes“ (EAP) an Patienten mit ausbehandeltem NSCLC. Pneumologie 2005. [DOI: 10.1055/s-2005-864561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
Häussinger K, Ballin A, Becker HD, Bölcskei P, Dierkesmann R, Dittrich I, Frank W, Freitag L, Gottschall R, Guschall WR, Hartmann W, Hauck R, Herth F, Kirsten D, Kohlhäufl M, Kreuzer A, Loddenkemper R, Macha N, Markus A, Stanzel F, Steffen H, Wagner M. Empfehlungen zur Sicherung der Qualität in der Bronchoskopie. Pneumologie 2004; 58:344-56. [PMID: 15162262 DOI: 10.1055/s-2004-818406] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- K Häussinger
- Asklepios Fachkliniken München-Gauting, Zentrum für Pneumologie und Thoraxchirurgie.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Ukena D, Schroeder M, Dittrich I, Guschall WR, Ko YD, Welte T, Hetzel M, Appel T, Schütte W. Chemotherapie des nicht kleinzelligen Bronchialkarzinoms (NSCLC) Stadium IIIB/IV mit Paclitaxel und Carboplatin: Wöchentliche versus 3-wöchentliche Therapie. Pneumologie 2004. [DOI: 10.1055/s-2004-819732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
10
|
Schütte W, Schroeder M, Dittrich I, Guschall WR, Ko YD, Welte T, Hetzel M, Appel T, Ukena D. Chemotherapie des nicht kleinzelligen Bronchialkarzinoms (NSCLC) Stadium IIIB/IV mit Paclitaxel und Carboplatin: Vergleich der Verträglichkeit bei wöchentlicher und 3-wöchentlicher Applikation der Zytostatika. Pneumologie 2004. [DOI: 10.1055/s-2004-819702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
11
|
Paukisch H, Weihrich T, Ruhnow U, Guschall W, Dittrich I, Bahnsen J. Are dose volume histograms a valuable tool in predicting clinically significant pneumonitis using conformal radiotherapy in locally advanced NSCLC? Eur J Cancer 2001. [DOI: 10.1016/s0959-8049(01)81228-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Guschall WR, Floegel R, Liebetrau G, Dittrich I. Small cell lung cancer: Stage, therapy, surviving — Analysis of a non selected patient collective 1993–1997. Lung Cancer 2000. [DOI: 10.1016/s0169-5002(00)80907-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Guschall WR, Schneemann-Heinze S, Floegel R, Liebetrau G, Dittrich I. The therapy of the inoperable non small cell lung cancer: Radiotherapy vs. radio-chemotherapy. Lung Cancer 2000. [DOI: 10.1016/s0169-5002(00)80382-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Dittrich I, Floegel R, Liebetrau G, Guschall WR. Non tumor conditional death of patients with small cell lung cancer. Lung Cancer 2000. [DOI: 10.1016/s0169-5002(00)80756-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
15
|
Guschall WR, Dittrich I, Gatzemeier U, Serke M, Riedel U, Mehl B, Baumgart J, Drings P. Clinical phase II trial of intravenous treosulfan in patients with non-pretreated metastatic small-cell lung cancer. Lung Cancer 1999. [DOI: 10.1016/s0169-5002(99)90799-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Reisinger I, Bohuslavitzki KH, Brenner W, Braune S, Dittrich I, Geide A, Kettner B, Otto HJ, Schmidt S, Munz DL. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 1998; 39:224-7. [PMID: 9476922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
UNLABELLED The aims of this study were to determine the accuracy of somatostatin receptor scintigraphy in the detection of the primary tumor and its metastases in small-cell lung cancer (SCLC) in a large patient population, and to investigate the course of somatostatin uptake in primary tumors during therapy. METHODS In a total of 100 patients, 134 examinations were performed. Twenty-seven of the patients were examined before and after chemotherapy. Planar whole-body images were acquired 4 hr and 24 hr after injection of approximately 200 MBq (111)In-pentetreotide. SPECT of the thorax was performed after 24 hr. Tumor-to-background (T/B) ratios for the primary tumor were averaged from anterior and posterior projections. RESULTS Compared to conventional investigations, somatostatin receptor scintigraphy (SRS) visualized the primary tumor with varying degrees of uptake in 96% of the examinations. Regional metastases and distant metastases were detected in 60% and 45% of the examinations, respectively. The uptake of the somatostatin analog by the primary tumor was significantly lower in the patients examined during chemotherapy as compared to those examined before treatment (T/B ratio = 1.94+/-0.79 versus 2.35+/-0.9, p < 0.005). A decrease in T/B ratio was noted in patients with remission at the time of SRS (from 2.40+/-1.56 to 1.63+/-0.72, p < 0.05). No difference in the pretreatment uptake of octreotide by the primary tumor was identified between patients with tumor progression and those with partial or complete remission. CONCLUSION Somatostatin receptor scintigraphy has a high sensitivity in the detection of the primary tumor in SCLC but fails in the detection of metastases. Thus, SRS does not provide useful information for staging of SCLC. Since somatostatin uptake by the primary tumor is affected by chemotherapy, it may be used to follow up on the course of SCLC.
Collapse
Affiliation(s)
- I Reisinger
- Clinic for Nuclear Medicine, Universitätsklinikum Charité, Humboldt-Universität, Berlin, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|